Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU5D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,160
Award facts
- Contract value 100% obligated
- $47,159.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a $47,159.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, a pharmaceutical product used in cancer treatment. The contract is classified as a child award under the parent entity Cencora, Inc. (doing business as AmerisourceBergen) and carries an ultimate completion date of February 5, 2026. This is a non-set-aside contract awarded through competitive procurement, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The IDC enables the company to supply an extensive portfolio of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains—to support Defense Health Agency programs and other federal healthcare systems worldwide. AmerisourceBergen's consistent receipt of competitively awarded contracts and its significant IDC position demonstrate its established capability to meet federal medical supply requirements at scale.
Quick answers
Who was awarded contract SPE2DR26FQU5D?
SPE2DR26FQU5D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FQU5D worth?
The government has obligated $47,160 on SPE2DR26FQU5D.
Is contract SPE2DR26FQU5D an order under another contract?
Yes. SPE2DR26FQU5D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU5D competed?
The extent of competition for SPE2DR26FQU5D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award